TY - CHAP
T1 - Monitoring Oral Anticoagulant Therapy
AU - Tripodi, A.
PY - 2009/3/4
Y1 - 2009/3/4
KW - "model for end-stage liver disease (MELD)" score
KW - Conversion of PT into INR and issues affecting results
KW - Implementation of INR
KW - International Sensitivity Index
KW - IRPs crucial for model of WHO calibration
KW - Mean normal prothrombin time
KW - Oral anticoagulant therapy
KW - Thromboplastin calibration
KW - Vitamin K antagonists (VKA) - oral anticoagulants for venous thromboembolism
UR - http://www.scopus.com/inward/record.url?scp=77955854151&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77955854151&partnerID=8YFLogxK
U2 - 10.1002/9781444303575.ch18
DO - 10.1002/9781444303575.ch18
M3 - Chapter
AN - SCOPUS:77955854151
SN - 9781405168038
SP - 179
EP - 189
BT - Quality in Laboratory Hemostasis and Thrombosis
PB - Wiley-Blackwell
ER -